Advertisement

Topics

Latest "Zenobia Therapeutics" News Stories

16:36 EST 16th January 2018 | BioPortfolio

Here are the most relevant search results for "Zenobia Therapeutics" found in our extensive news archives from over 250 global news sources.

More Information about Zenobia Therapeutics on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Zenobia Therapeutics for you to read. Along with our medical data and news we also list Zenobia Therapeutics Clinical Trials, which are updated daily. BioPortfolio also has a large database of Zenobia Therapeutics Companies for you to search.

Showing "Zenobia Therapeutics" News Articles 1–25 of 7,100+

Relevant

Concurrent with BMS acquisition, IFM Therapeutics spins off IFM Therapeutics LLC

Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC. ...


Global Veterinary Therapeutics Market to Mark CAGR of 6.0% Over Next 10 Years - MarketResearch.biz

MarketResearch.biz announces publication of its recently generated research report titled, "GlobalVeterinary Therapeutics MarketBy Type (Therapeutics Drugs, Therapeutics Vaccines, Feed Additives Therapeutics), By Read more...

Deals this week: Nabriva Therapeutics, LifeMine Therapeutics, Aldeyra Therapeutics

Nabriva Therapeutics plans to raise $80m through an underwritten public offering of shares of its common stock.


ProQR spins out Amylon Therapeutics for CNS therapeutics

ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of institutional and private investors. As part of the transaction, ProQR has granted an exclusive license to Amylon to develop therapeutics for beta amyloid related disorders. Amylon […] The post ProQ...

Technical Perspectives on Argos Therapeutics, Omeros, Regulus Therapeutics, and Rhythm Pharma

Argos Therapeutics Durham, North Carolinaheadquartered Argos Therapeutics Inc.'s stock finished last Friday's session 3.20% higher at $0.15. A total volume of 1.81 million Read more...

Capricor Therapeutics to Present at the Piper Jaffray Healthcare Conference

About Capricor Therapeutics Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapeutics Read more...

Deals this week: Odonate Therapeutics, China Reform Holdings, Denali Therapeutics

US-based therapeutics developer Odonate Therapeutics LLC plans to raise $182.57m through an initial public offering (IPO) of 6,762,000 shares of...Read More... The post Deals this week: Odonate Therapeutics, China Reform Holdings, Denali Therapeutics appeared first on Drug Development Technology.

Breakfast Technical Briefing on Biotech Stocks -- Cytori Therapeutics, Sorrento Therapeutics, ...

http://dailystocktracker.com/register/ Cytori Therapeutics San Diego, Californiaheadquartered Cytori Therapeutics Inc.'s shares dropped 2.15%, closing Monday's trading session at $0.39. The stock recorded a trading Read more...

Summit Therapeutics plc: Summit Therapeutics to Participate in Upcoming Investor Conferences

Summit Therapeutics plc ('Summit', or the 'Company')SUMMIT THERAPEUTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCESOxford, UK, 22 November 2017- Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUM...

SMi Group announces the 9th Annual RNA Therapeutics Conference

21 - 22 February 2018, London, UK. As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo...

Realm Therapeutics to Present at the 2017 BIO Investor Forum

MALVERN, PA -- (Marketwired) -- 10/16/17 -- Realm Therapeutics PLC (AIM: RLM) (AIM: RLM) Realm Therapeutics plc ("Realm Therapeutics", "Realm" or the "Company") Realm Therapeutics to Present at th...

3 Biotech Stocks That Exploded in 2017

Biotech companies Nektar Therapeutics, Esperion Therapeutics, and Sangamo Therapeutics led the market this year.

Head-To-Head Survey: Anika Therapeutics (ANIK) versus Its Peers

Anika Therapeutics is one of 45 public companies in the "Biopharmaceuticals" industry, but how does it compare to its competitors? We will compare Anika Therapeutics to related companies based on the strength of its dividends, profitability, risk, institutional ownership, analyst recommendations, earnings and valuation. Anika Therapeutics' competitors have higher revenue and earnings than Anik...

iCo Therapeutics Announces Ethics Approval for its Oral Amphotericin B Phase 1 Clinical Study

Vancouver, British Columbia--(Newsfile Corp. - November 22, 2017) - iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company"), and its recently formed subsidiary iCo Therapeutics Au...

PEAR raises $50m to develop digital therapeutics business

PEAR Therapeutics has raised $50m in a new financing round to fund development of its prescription digital therapeutics business. Prescription digital therapeutics are clinically-validated, FDA-cleared software applications that demonstrate safety...

Acer Therapeutics receives $15.7mm investment

Acer Therapeutics Inc. (rare disease therapeutics) received $15.7mm (includes $5.7mm in conversion of convertible notes) from...

Bone Therapeutics SA : Publie son rapport d’activité du T1 2017

Bone Therapeutics SA — Thursday, August 24th 2017 at 5:01am UTC Bone Therapeutics publiera ses résultats semestriels, le 31 août 2017 Gosselies, Belgique, le 24 août 2017, 7h00 CET – BONE THERAPEUTICS (Euronext Bruxelles et Paris: BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux non satisfaits dans les domaines de l’orthopé...

Immune-Onc Therapeutics Awarded "Buzz of BIO"

PALO ALTO, Calif.--(BUSINESS WIRE)--Immune-Onc Therapeutics, Inc. ("Immune-Onc"), a new biopharmaceutical company focused on advancing immuno-oncology therapeutics, announced that the Biotechnology Innovation Organization (BIO) has named the Company "

Probably Relevant

What You Need to Know About Relay Therapeutics

Based in Cambridge, MA and founded in February 2016, Relay Therapeutics focuses on developing therapeutics based on protein motion.

CSE: 2017-1012 - Delist - Pivotal Therapeutics Inc. (PVO)

TORONTO, ONTARIO -- (Marketwired) -- 10/23/17 -- The common shares of Pivotal Therapeutics Inc. will be delisted at the market close today, October 23, 2017. Pivotal Therapeutics is currently susp...

CanniMed Therapeutics: Ring frei!

Aurora Cannabis Inc. will den kanadischen Mitbewerber CanniMed Therapeutics schlucken. Das Management von CanniMed Therapeutics zeigte sich mit Blick auf die "Aurora-Offerte" nur mäßig erfreut. Ein...

CureVac and Arcturus Collaborate to Advance Next Generation of Lipid-Mediated mRNA Therapeutics

TÜBINGEN, Germany & BOSTON & SAN DIEGO–(BUSINESS WIRE)–CureVac AG, a leading clinical-stage biopharmaceutical company focused on the development of pioneering mRNA therapeutics, and Arcturus Therapeutics Ltd. (NASDAQ:ARCT), an RNA medicines company, today announced they have entered into a broad strategic collaboration to jointly discover, develop and commercialize novel messe...

Spark Therapeutics, Inc.: Spark Therapeutics nimmt an mehreren Konferenzen im Januar teil

PHILADELPHIA (USA), 3. Januar 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), ein voll integriertes Gentherapie-Unternehmen, das infrage stellt, dass genetische Krankheiten unvermeidbar...

Silence Therapeutics sells more of its holding in Arrowhead

RNA-based therapeutics discovery and development company Silence Therapeutics has sold a further part of its holding of common shares in Arrowhead Pharmaceuticals, it announced on Monday. The AIM-t...

Crestovo, Finch Therapeutics merge to create fully-integrated microbiome company

Finch Therapeutics Inc. is merging with fellow closely held microbiome company Crestovo to form Finch Therapeutics Group.


Quick Search
Advertisement
 

News Quicklinks